You have no items in your shopping cart.
LY 344864
SKU: orb1703992
Description
Research Area
Neuroscience, Pharmacology & Drug Discovery
Images & Validation
−
Key Properties
−| CAS Number | 186544-26-3 |
|---|---|
| MW | 351.42 |
| Purity | 98.00% |
| Formula | C21H22FN3O |
| SMILES | Cl.CN(C)[C@@H]1CCc2[nH]c3ccc(NC(=O)c4ccc(F)cc4)cc3c2C1 |
| Target | 5-HT Receptor,Adrenergic Receptor |
| Solubility | DMSO:>10 mM;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.69 mM) |
Bioactivity
−| Target IC50 |
|---|
Storage & Handling
−| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
|---|---|
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−Beta Receptor, BBB penetration, 5HTReceptor, 5-hydroxytryptamine Receptor, 5-HT1F, 5-HT Receptor, 5HT Receptor, Adrenergic Receptor, Inhibitor, inhibit, LY 344864, Parkinson's disease, LY344864, LY-344864, migraines, Serotonin Receptor
Similar Products
−LY 344864 racemate [orb1703984]
99.75%
186543-64-6
351.42
C21H22FN3O
5 mg, 50 mg, 10 mg, 25 mg, 1 ml x 10 mM (in DMSO), 100 mgLY 344864 racemate [orb2901462]
>98% (HPLC)
186543-64-6
5 mg, 1 g, 500 mg, 100 mg, 10 mg, 25 mg, 50 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Compound Identifiers
PubChem CID
Key Properties
− No computed properties available.
Documents Download
Datasheet
Product Information
Request a Document
Protocol Information
LY 344864 (orb1703992)
Based on 0 reviews
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review